← All organizations
Highest phase reached
Phase 3
First clinical trial
Jan 1, 2013Last known activity
Oct 31, 2023
Timeline
No events for the selected filters.
Drugs by trial phase (4 distinct, 3 trials)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (4)
- NCT06081348CollaboratorPhase 2Oct 31, 2023
- NCT03808935Lead sponsorPhase 3Jan 10, 2019
- NCT03808935CollaboratorPhase 3Jan 10, 2019
- NCT01769092CollaboratorPhase 2/Phase 3Jan 1, 2013
Details
- Last known activity
- Oct 31, 2023